{
    "info": {
        "nct_id": "NCT03299309",
        "official_title": "The PRiME Study: PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma",
        "inclusion_criteria": "1. Patients who are 3 - 35 years old\n2. Histopathologically proven previous diagnosis of medulloblastoma or Grade III or IV glioma.\n3. Radiology evidence of recurrent medulloblastoma (reMB) or recurrent Grade III and IV glioma. Patients will be considered for a biopsy or resection of the recurrent/progressive tumor at the discretion of the treating neurosurgeon and neuro-oncologist.\n4. Brain MRI within one month prior to enrollment.\n5. Received prior therapy for their initial diagnosis prior to recurrence/progression or who are unable to receive radiation therapy due to genetic disorders that put them at significant risk for radiation-induced secondary malignancies (i.e. Gorlin's syndrome or NF1 mutation).\n6. Patients with neurological deficits should have deficits that are stable for a minimum of 2 weeks prior to registration.\n7. Karnofsky Performance Status (KPS) of ≥ 60% (KPS for > 10 years of age) or Lansky performance Score (LPS) of ≥ 60 (LPS for ≤ 10 years of age) assessed within 2 weeks prior to registration. Patients who are unable to walk because of paralysis but who are up in a wheel chair will be considered ambulatory for the purposes of the performance score.\n8. Bone Marrow:\n\n   * ANC (Absolute neutrophil count) ≥ 1000/µl (unsupported)*.\n   * Platelets ≥ 100,000/µl (unsupported)*.\n   * Hemoglobin > 8 g/dL (may be supported).\n9. Renal:\n\n   • Serum creatinine ≤ upper limit of institutional normal.\n10. Hepatic:\n\n    * Bilirubin ≤ 1.5 times upper limit of normal for age.\n    * SGPT (ALT) ≤ 3 times institutional upper limit of normal for age.\n    * SGOT (AST) ≤ 3 times institutional upper limit of normal for age.\n11. Patients of childbearing or child-fathering potential must be willing to use a medically acceptable form of birth control, which includes abstinence, while being treated on this study.\n12. Signed informed consent according to institutional guidelines must be obtained prior to registration.\n13. Any prior chemoradiotherapy is allowed.\nHealthy volunteers allowed\nMust have minimum age of 3 Years\nMust have maximum age of 35 Years",
        "exclusion_criteria": "1. Pregnant or need to breast feed during the study period (Negative serum pregnancy test required).\n2. Active infection requiring treatment or an unexplained febrile (> 101.5 degrees F) illness.\n3. Known immunosuppressive disease or human immunodeficiency virus infection.\n4. Patients with active renal, cardiac (congestive cardiac failure, myocardial infarction, myocarditis), or pulmonary disease.\n5. Patients receiving concomitant immunosuppressive agents for medical condition.\n6. Patients who need definitive radiotherapy for treatment of recurrent MB or recurrent Grade III or IV glioma.\n7. Patients receiving any other investigational drug therapy.\n8. Patients on corticosteroids > 0.1 mg/Kg/day (i.e. > the maximum dose of 4 mg/day).\n9. Patients with any clinically significant unrelated systemic illness (serious infections or significant cardiac, pulmonary, hepatic or other organ dysfunction).\n10. Patients with inability to return for follow-up visits or obtain follow-up studies required to assess toxicity to therapy.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must have maximum age of 35 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 35 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 35,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "• Serum creatinine ≤ upper limit of institutional normal.",
            "criterions": [
                {
                    "exact_snippets": "Serum creatinine ≤ upper limit of institutional normal",
                    "criterion": "serum creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "upper limit of institutional normal"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "10. Hepatic:",
            "criterions": [
                {
                    "exact_snippets": "Hepatic:",
                    "criterion": "hepatic function",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "criterion heading only; no specific requirement provided"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Patients who are 3 - 35 years old",
            "criterions": [
                {
                    "exact_snippets": "Patients who are 3 - 35 years old",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 3,
                                        "unit": "years"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 35,
                                        "unit": "years"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 3 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 3 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ANC (Absolute neutrophil count) ≥ 1000/µl (unsupported)*.",
            "criterions": [
                {
                    "exact_snippets": "ANC (Absolute neutrophil count) ≥ 1000/µl",
                    "criterion": "absolute neutrophil count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1000,
                                "unit": "/µl"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Bone Marrow:",
            "criterions": [
                {
                    "exact_snippets": "Bone Marrow:",
                    "criterion": "bone marrow",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "criterion to be specified in subsequent text"
                        }
                    ]
                }
            ]
        },
        {
            "line": "9. Renal:",
            "criterions": [
                {
                    "exact_snippets": "Renal:",
                    "criterion": "renal function",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "N/A"
                        }
                    ]
                }
            ]
        },
        {
            "line": "12. Signed informed consent according to institutional guidelines must be obtained prior to registration.",
            "criterions": [
                {
                    "exact_snippets": "Signed informed consent ... must be obtained prior to registration.",
                    "criterion": "informed consent",
                    "requirements": [
                        {
                            "requirement_type": "signed",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to registration"
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Patients with neurological deficits should have deficits that are stable for a minimum of 2 weeks prior to registration.",
            "criterions": [
                {
                    "exact_snippets": "Patients with neurological deficits should have deficits that are stable for a minimum of 2 weeks prior to registration.",
                    "criterion": "neurological deficits",
                    "requirements": [
                        {
                            "requirement_type": "stability_duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "weeks"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Received prior therapy for their initial diagnosis prior to recurrence/progression or who are unable to receive radiation therapy due to genetic disorders that put them at significant risk for radiation-induced secondary malignancies (i.e. Gorlin's syndrome or NF1 mutation).",
            "criterions": [
                {
                    "exact_snippets": "Received prior therapy for their initial diagnosis prior to recurrence/progression",
                    "criterion": "prior therapy for initial diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "history of prior therapy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "unable to receive radiation therapy due to genetic disorders that put them at significant risk for radiation-induced secondary malignancies (i.e. Gorlin's syndrome or NF1 mutation)",
                    "criterion": "genetic disorders increasing risk of radiation-induced secondary malignancies",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "genetic disorder type",
                            "expected_value": [
                                "Gorlin's syndrome",
                                "NF1 mutation"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Bilirubin ≤ 1.5 times upper limit of normal for age.",
            "criterions": [
                {
                    "exact_snippets": "Bilirubin ≤ 1.5 times upper limit of normal for age.",
                    "criterion": "bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "times upper limit of normal for age"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Brain MRI within one month prior to enrollment.",
            "criterions": [
                {
                    "exact_snippets": "Brain MRI within one month prior to enrollment.",
                    "criterion": "brain MRI",
                    "requirements": [
                        {
                            "requirement_type": "performed_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "month prior to enrollment"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Histopathologically proven previous diagnosis of medulloblastoma or Grade III or IV glioma.",
            "criterions": [
                {
                    "exact_snippets": "Histopathologically proven previous diagnosis of medulloblastoma",
                    "criterion": "medulloblastoma diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "histopathological confirmation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "previous diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Histopathologically proven previous diagnosis of ... Grade III or IV glioma",
                    "criterion": "glioma diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "histopathological confirmation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "previous diagnosis",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "grade",
                            "expected_value": [
                                "III",
                                "IV"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "13. Any prior chemoradiotherapy is allowed.",
            "criterions": [
                {
                    "exact_snippets": "Any prior chemoradiotherapy is allowed.",
                    "criterion": "prior chemoradiotherapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hemoglobin > 8 g/dL (may be supported).",
            "criterions": [
                {
                    "exact_snippets": "Hemoglobin > 8 g/dL",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 8,
                                "unit": "g/dL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Platelets ≥ 100,000/µl (unsupported)*.",
            "criterions": [
                {
                    "exact_snippets": "Platelets ≥ 100,000/µl (unsupported)",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100000,
                                "unit": "/µl"
                            }
                        },
                        {
                            "requirement_type": "support",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* SGPT (ALT) ≤ 3 times institutional upper limit of normal for age.",
            "criterions": [
                {
                    "exact_snippets": "SGPT (ALT) ≤ 3 times institutional upper limit of normal for age.",
                    "criterion": "SGPT (ALT) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "times institutional upper limit of normal for age"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* SGOT (AST) ≤ 3 times institutional upper limit of normal for age.",
            "criterions": [
                {
                    "exact_snippets": "SGOT (AST) ≤ 3 times institutional upper limit of normal for age.",
                    "criterion": "SGOT (AST) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "times institutional upper limit of normal for age"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Radiology evidence of recurrent medulloblastoma (reMB) or recurrent Grade III and IV glioma. Patients will be considered for a biopsy or resection of the recurrent/progressive tumor at the discretion of the treating neurosurgeon and neuro-oncologist.",
            "criterions": [
                {
                    "exact_snippets": "Radiology evidence of recurrent medulloblastoma (reMB)",
                    "criterion": "recurrent medulloblastoma",
                    "requirements": [
                        {
                            "requirement_type": "radiology evidence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Radiology evidence of ... recurrent Grade III and IV glioma",
                    "criterion": "recurrent Grade III and IV glioma",
                    "requirements": [
                        {
                            "requirement_type": "radiology evidence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "11. Patients of childbearing or child-fathering potential must be willing to use a medically acceptable form of birth control, which includes abstinence, while being treated on this study.",
            "criterions": [
                {
                    "exact_snippets": "Patients of childbearing or child-fathering potential",
                    "criterion": "childbearing or child-fathering potential",
                    "requirements": [
                        {
                            "requirement_type": "potential",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "must be willing to use a medically acceptable form of birth control, which includes abstinence, while being treated on this study",
                    "criterion": "use of medically acceptable birth control",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "usage",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "while being treated on this study"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "7. Patients receiving any other investigational drug therapy.",
            "criterions": [
                {
                    "exact_snippets": "Patients receiving any other investigational drug therapy",
                    "criterion": "investigational drug therapy",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Patients who need definitive radiotherapy for treatment of recurrent MB or recurrent Grade III or IV glioma.",
            "criterions": [
                {
                    "exact_snippets": "Patients who need definitive radiotherapy",
                    "criterion": "need for definitive radiotherapy",
                    "requirements": [
                        {
                            "requirement_type": "necessity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "recurrent MB or recurrent Grade III or IV glioma",
                    "criterion": "diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "disease type",
                            "expected_value": [
                                "recurrent medulloblastoma (MB)",
                                "recurrent Grade III glioma",
                                "recurrent Grade IV glioma"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Active infection requiring treatment or an unexplained febrile (> 101.5 degrees F) illness.",
            "criterions": [
                {
                    "exact_snippets": "Active infection requiring treatment",
                    "criterion": "active infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "unexplained febrile (> 101.5 degrees F) illness",
                    "criterion": "febrile illness",
                    "requirements": [
                        {
                            "requirement_type": "explanation",
                            "expected_value": "unexplained"
                        },
                        {
                            "requirement_type": "temperature",
                            "expected_value": {
                                "operator": ">",
                                "value": 101.5,
                                "unit": "degrees F"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Pregnant or need to breast feed during the study period (Negative serum pregnancy test required).",
            "criterions": [
                {
                    "exact_snippets": "Pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "need to breast feed during the study period",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Negative serum pregnancy test required",
                    "criterion": "serum pregnancy test",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        }
                    ]
                }
            ]
        },
        {
            "line": "10. Patients with inability to return for follow-up visits or obtain follow-up studies required to assess toxicity to therapy.",
            "criterions": [
                {
                    "exact_snippets": "inability to return for follow-up visits",
                    "criterion": "ability to return for follow-up visits",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "inability to ... obtain follow-up studies required to assess toxicity to therapy",
                    "criterion": "ability to obtain follow-up studies required to assess toxicity to therapy",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Patients with active renal, cardiac (congestive cardiac failure, myocardial infarction, myocarditis), or pulmonary disease.",
            "criterions": [
                {
                    "exact_snippets": "active renal ... disease",
                    "criterion": "renal disease",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "active ... cardiac (congestive cardiac failure, myocardial infarction, myocarditis) ... disease",
                    "criterion": "cardiac disease",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "active ... pulmonary disease",
                    "criterion": "pulmonary disease",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Patients receiving concomitant immunosuppressive agents for medical condition.",
            "criterions": [
                {
                    "exact_snippets": "Patients receiving concomitant immunosuppressive agents",
                    "criterion": "immunosuppressive agent use",
                    "requirements": [
                        {
                            "requirement_type": "concomitant use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "for medical condition",
                    "criterion": "medical condition requiring immunosuppression",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "9. Patients with any clinically significant unrelated systemic illness (serious infections or significant cardiac, pulmonary, hepatic or other organ dysfunction).",
            "criterions": [
                {
                    "exact_snippets": "clinically significant unrelated systemic illness (serious infections or significant cardiac, pulmonary, hepatic or other organ dysfunction)",
                    "criterion": "clinically significant unrelated systemic illness",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "serious infections",
                    "criterion": "serious infections",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "significant cardiac ... dysfunction",
                    "criterion": "significant cardiac dysfunction",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "significant ... pulmonary ... dysfunction",
                    "criterion": "significant pulmonary dysfunction",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "significant ... hepatic ... dysfunction",
                    "criterion": "significant hepatic dysfunction",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "significant ... other organ dysfunction",
                    "criterion": "significant other organ dysfunction",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Known immunosuppressive disease or human immunodeficiency virus infection.",
            "criterions": [
                {
                    "exact_snippets": "Known immunosuppressive disease",
                    "criterion": "immunosuppressive disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "awareness/status",
                            "expected_value": "known"
                        }
                    ]
                },
                {
                    "exact_snippets": "human immunodeficiency virus infection",
                    "criterion": "human immunodeficiency virus (HIV) infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Patients on corticosteroids > 0.1 mg/Kg/day (i.e. > the maximum dose of 4 mg/day).",
            "criterions": [
                {
                    "exact_snippets": "Patients on corticosteroids > 0.1 mg/Kg/day (i.e. > the maximum dose of 4 mg/day)",
                    "criterion": "corticosteroid dose",
                    "requirements": [
                        {
                            "requirement_type": "dose",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">",
                                        "value": 0.1,
                                        "unit": "mg/Kg/day"
                                    },
                                    {
                                        "operator": ">",
                                        "value": 4,
                                        "unit": "mg/day"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "7. Karnofsky Performance Status (KPS) of ≥ 60% (KPS for > 10 years of age) or Lansky performance Score (LPS) of ≥ 60 (LPS for ≤ 10 years of age) assessed within 2 weeks prior to registration. Patients who are unable to walk because of paralysis but who are up in a wheel chair will be considered ambulatory for the purposes of the performance score.",
            "criterions": [
                {
                    "exact_snippets": "Karnofsky Performance Status (KPS) of ≥ 60% (KPS for > 10 years of age) assessed within 2 weeks prior to registration",
                    "criterion": "Karnofsky Performance Status (KPS)",
                    "requirements": [
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": ">",
                                "value": 10,
                                "unit": "years"
                            }
                        },
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "%"
                            }
                        },
                        {
                            "requirement_type": "assessment_timeframe",
                            "expected_value": "within 2 weeks prior to registration"
                        }
                    ]
                },
                {
                    "exact_snippets": "Lansky performance Score (LPS) of ≥ 60 (LPS for ≤ 10 years of age) assessed within 2 weeks prior to registration",
                    "criterion": "Lansky Performance Score (LPS)",
                    "requirements": [
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": "<=",
                                "value": 10,
                                "unit": "years"
                            }
                        },
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": ""
                            }
                        },
                        {
                            "requirement_type": "assessment_timeframe",
                            "expected_value": "within 2 weeks prior to registration"
                        }
                    ]
                },
                {
                    "exact_snippets": "Patients who are unable to walk because of paralysis but who are up in a wheel chair will be considered ambulatory for the purposes of the performance score",
                    "criterion": "ambulatory status for performance score",
                    "requirements": [
                        {
                            "requirement_type": "paralysis with wheelchair use",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "ambulatory classification for performance score",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}